Free Float 71,46 %
Shares Float 16,18 M
Shares Outstanding 22,64 M
ASARINA PHARMA AB
Share · SE0011641794 · A2N6U6 (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ASARINA PHARMA AB
No Price
Share Float & Liquidity
Company Profile for ASARINA PHARMA AB Share
Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.
Company Data
Name ASARINA PHARMA AB
Company Asarina Pharma AB (publ)
Website
https://www.asarinapharma.com
Primary Exchange 
NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
WKN A2N6U6
ISIN SE0011641794
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Peter Nordkild
Country Sweden
Currency SEK
Employees 0,0 T
Address Karolinska Institutet Science Park, 171 65 Solna
IPO Date 2018-09-24
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | ASAP.ST |
| Frankfurt | APS.F |
More Shares
Investors who hold ASARINA PHARMA AB also have the following shares in their portfolio:
